Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topamax vs Placebo for Migraine Prophylaxis
NCT00253175Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in migraine, sponsored by Johnson & Johnson. Started Oct 2000; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00253175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253175.